The role of harm reduction in controlling HIV among injecting drug users.
about
Stigma and Human Rights Abuses against People Who Inject Drugs in Russia--A Qualitative Investigation to Inform Policy and Public Health StrategiesThe context of HIV risk behaviours among HIV-positive injection drug users in Viet Nam: moving toward effective harm reductionHIV and HCV prevalence and incarceration-related risks among injecting drug users in three West Bank governorates.Re-thinking global health sector efforts for HIV and tuberculosis epidemic control: promoting integration of programme activities within a strengthened health system.HIV/AIDS-related stigmatizing and discriminatory attitudes and recent HIV testing among men who have sex with men in Beijing."Until people start dying in droves, no actions will be taken": perception and experience of HIV-preventive measures among people who inject drugs in northwestern RussiaMethadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug usersSelf-esteem in HIV-positive and HIV-negative gay and bisexual men: implications for risk-taking behaviors with casual sex partners.Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviourBehavioural strategies to reduce HIV transmission: how to make them work better.Prevention of HIV infection among injection drug users in resource-limited settings.Interventions for families affected by HIVHow far will they go? Assessing the travel distance of current and former drug users to access harm reduction services.Client-identified needs and agency-provided services at a harm reduction community based organization in the District of ColumbiaThe evidence does not speak for itself: The role of research evidence in shaping policy change for the implementation of publicly funded syringe exchange programs in three US citiesBlame, symbolic stigma and HIV misconceptions are associated with support for coercive measures in urban India.Improving community health and safety in Canada through evidence-based policies on illegal drugs.Trends and determinants of HIV/AIDS knowledge among women in Bangladesh.HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients.Assessing seasonality of travel distance to harm reduction service providers among persons who inject drugs.Empathy and avoidance in treating patients living with HIV/AIDS (PLWHA) among service providers in China.Blocking the benefit of group-based HIV-prevention efforts during adolescence: the problem of HIV-related stigma.The influence of social determinants on evidence-based behavioral interventions-considerations for implementation in community settings.Impact Evaluation of a Policy Intervention for HIV Prevention in Washington, DCClient-Level Coverage of Needle and Syringe Program and High-Risk Injection Behaviors: A Case Study of People Who Inject Drugs in Kermanshah, Iran.Assessing Syringe Exchange Program Access among Persons Who Inject Drugs (PWID) in the District of ColumbiaHIV prevention: What have we learned from community experiences in concentrated epidemics?Older female caregivers and HIV/AIDS-related secondary stigma in rural South Africa.Syringe exchange, injecting and intranasal drug use.Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects.Effect of peer-led outreach activities on injecting risk behavior among male drug users in Haryana, IndiaCoverage of harm reduction services and HIV infection: a multilevel analysis of five Chinese cities.Persistent racial/ethnic disparities in AIDS diagnosis rates among people who inject drugs in U.S. metropolitan areas, 1993-2007.Predictors of late presentation for HIV diagnosis: a literature review and suggested way forward.HIV in Africa: Challenges and Directions for the Next Decade.Duty and destiny: psychometric properties and correlates of HIV-related stigma among youth NGO workers in Delhi, India.Socioeconomic disadvantage increasing risk for depression among recently diagnosed HIV patients in an urban area in Brazil: cross-sectional study.Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who Smoke.Broadening Substance Use(r) Research and Intervention Efforts to Address Context.Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates.
P2860
Q28547476-7E204D39-8A3D-4153-8CC5-43FB8D2BFB26Q33427206-E51E100A-2B8C-49B9-911A-A6277F5305A5Q33458008-F206DDBB-8636-40A4-A349-4DB87C49997AQ33625404-8307673D-345F-43A4-956A-EB7311D4491FQ33720884-A73B9864-4723-450B-A827-A0C43C7C4CF6Q33767781-E8E1EC95-5E23-4BBD-9431-38E38EACB0B5Q33802147-8800DF87-344C-42B5-B61F-385658184E73Q33930528-C1B0C146-CC29-427C-8461-8C56C149314FQ34105570-80FCEBC4-9371-46CE-93B1-341EA245AEBBQ34595298-294F4684-194B-4E5B-9C61-45C1524719A7Q35043964-4C0C3052-7FA6-47CE-94EB-0A1ABB690B02Q35061990-B3E72962-5D8A-4B7A-B33F-94FA00214919Q35158564-CCF91AA1-709A-4793-B0F1-2157F9E8C0CEQ35681690-3E53CBC6-88CE-487F-8AC1-259972C08699Q35744291-15517BEF-0D0B-4C67-9CB1-67D7E4958469Q35854890-55E7DB48-7F74-40F5-A3B7-8D637E1E89A7Q35896342-B5C03B59-73E8-4E42-9282-E24306B1C42CQ36106313-A316FE23-3B1F-4EC2-9492-3A480D2A1986Q36106528-48E6B5AF-990D-4426-9685-C22F0DAF98D5Q36156931-7B1FE953-1A74-4284-9154-4FE3E39EEFCCQ36164645-48067740-869C-450B-8127-A4152273F736Q36299598-264F18E6-40A5-43D2-B0E1-C4FE9A534C3FQ36411155-A36486FE-259C-4341-9F47-33A2A07C82D7Q36471062-3EB9F14B-4F0F-4580-9030-8CFD1CB86867Q36543493-CA332851-DF75-4CB7-BAF1-5BDA1D69AE1EQ36693420-3352FDF1-413F-4C0E-9E41-4851DC151E51Q36975277-C7271EDB-8A6B-412E-B744-896B2F355004Q36981595-EE0E101D-5D7E-44B3-9164-44730C54F189Q37262719-77786011-49FC-42FD-891B-FC082A17ABA0Q37409652-6CA9C2CB-AFD4-41C7-8BCA-39E525F21A53Q37580634-5681706C-E44D-4E94-825D-860720E2DB96Q37640546-6756BB83-2EB3-48EA-B50D-CBD5E2696A26Q37696114-68C49DA0-1432-4FF3-862F-AC13FB8935F1Q37973262-08AB7E65-5DB6-4A51-85DE-E4F7078EE7F4Q38419599-41595C2E-E2A7-4C1A-9C23-8D4FCABB1310Q39658159-52CF6967-AF29-40EE-BC23-A27263A1F9C3Q40261645-43F23C8F-050C-4137-970D-17CF22391AA7Q41338916-A74B887E-03F0-403C-8F8D-C0F964601010Q43100972-8DD63F1F-19CF-4BF7-BAD9-C4733CB96B9EQ52299932-A42D15FE-BF72-4110-8738-87181891F500
P2860
The role of harm reduction in controlling HIV among injecting drug users.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The role of harm reduction in controlling HIV among injecting drug users.
@ast
The role of harm reduction in controlling HIV among injecting drug users.
@en
The role of harm reduction in controlling HIV among injecting drug users.
@nl
type
label
The role of harm reduction in controlling HIV among injecting drug users.
@ast
The role of harm reduction in controlling HIV among injecting drug users.
@en
The role of harm reduction in controlling HIV among injecting drug users.
@nl
prefLabel
The role of harm reduction in controlling HIV among injecting drug users.
@ast
The role of harm reduction in controlling HIV among injecting drug users.
@en
The role of harm reduction in controlling HIV among injecting drug users.
@nl
P2860
P1433
P1476
The role of harm reduction in controlling HIV among injecting drug users.
@en
P2093
Alex Wodak
Leah McLeod
P2860
P304
P356
10.1097/01.AIDS.0000327439.20914.33
P407
P478
22 Suppl 2
P50
P577
2008-08-01T00:00:00Z